“miR-145-5p and miR-203a-5p overcome imatinib resistance in myelogenous leukemic cells through metabolic reprogramming” (2023) Indian Journal of Biochemistry and Biophysics (IJBB), 60(3), pp. 167–176. doi:10.56042/ijbb.v60i3.66526.